Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,294,330
-$34,734,118 QoQ
Shares Held
26,091
-63.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#700
of 4,605 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. LLY ranks #4 (5.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
2,217,376 | $280,143,283 | |
| 2 | NVO |
Novo Nordisk A S
|
3,032,421 | $145,374,262 | |
| 3 | NVS |
Novartis AG
|
788,033 | $123,500,531 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
26,091 | $31,294,330 | |
| 5 | BIIB |
Biogen Inc.
|
77,744 | $16,797,368 | |
| 6 | AMRN |
Amarin Corp Plc\Uk
|
48,369 | $771,001 | |
| 7 | SCLX |
Scilex Holding Co
|
33,064 | $257,899 | |
| 8 | NSRX |
Nasus Pharma Ltd
|
12,200 | $42,700 |
All Filings in LLY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,294,330 | 26,091 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $66,028,448 | 71,788 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $178,232,470 | 165,847 | Shares | Sole | 2026-02-12 | |
| 2025-06-30 | $203,457 | 261 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $79,545,043 | 96,312 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $41,780,640 | 54,120 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $228,406,849 | 257,813 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $101,273,276 | 130,178 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $159,640,219 | 273,863 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $72,761,778 | 135,464 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,100,960 | 13,009 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $155,768,443 | 453,580 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $282,923,827 | 773,354 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $328,086,107 | 1,014,647 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,978,295 | 400,883 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $29,696,569 | 103,700 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $53,572,040 | 193,947 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $243,398,929 | 1,053,447 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $19,761,672 | 86,100 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $43,519,158 | 232,947 | Shares | Sole | 2021-05-13 | |
| 2020-09-30 | $71,278,586 | 481,547 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $100,797,818 | 613,947 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $29,769,312 | 214,600 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||